Alvotech and Advanz Pharma Announce Positive CHMP Opinion for AVT06 Biosimilar to Eylea®
23/6 10:10
Alvotech and Advanz Pharma announce positive EMA opinion for AVT06, a biosimilar to Eylea®, advancing access for eye disorder treatments in Europe....